CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 


Biotechnology & Drugs Industry Profitability

Profitability Information & Trends 
  
Select the Industry: Select the Category: Select the Period:

Biotechnology & Drugs Industry Profitability Ratios 1 Q 2017 4 Q 2016 3 Q 2016 2 Q 2016 1 Q 2016
  2017 2016 2016 2016 2016
Gross Margin 81.49 % 82.41 % 79.69 % 68.93 % 71.74 %
Gross Margin Annual (TTM) 82.41 % 82.55 % 80 % 71.35 % 73.1 %
Gross Margin Ranking # # # # #
EBITDA Margin 35.43 % 43.59 % 38.52 % - -
EBITDA Margin Annual (TTM) 38.51 % 39.46 % 37.11 % - -
EBITDA Margin Ranking # # # # #
Operating Margin 30.57 % 26.13 % 35.01 % - -
Operating Margin Annual (TTM) 31.68 % 34.16 % 34.15 % - -
Operating Margin Ranking # # # # #
Pre-Tax Margin 19.47 % 21.97 % 31.71 % - -
Pre-Tax Margin Annual (TTM) 26.28 % 30.33 % 30.8 % - -
Pre-Tax Margin Ranking # # # # #
Net Margin 14.08 % 18.91 % 24.69 % - -
Net Margin Annual (TTM) 35.1 % 39.26 % 24.25 % - -
Net Margin Ranking # # # # #


Gross Margin Comment

Biotechnology & Drugs Industry experienced contraction in Gross Profit by -4.48 % and Revenue by -3.44 %, while Gross Margin fell to 81.49 %, higher than Industry's average Gross Margin.

On the trailing twelve months basis gross margin in 1 Q 2017 fell to 82.41 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest gross margin. Total ranking remained unchanged compare to previous quarter at no. .

Note, first quarter Numbers include only companies who have reported first quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
0 % 0 % 0 %
 

Gross Margin Industry Ranking
Within: No.
Healthcare Sector #
S&P 500 #

You need to upgrade your Flash Player

Other Gross Margins
Compare Industry's gross margin to Pbi's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Pbi's Suppliers Definiton of Gross Margin

Biotechnology & Drugs Industry EBITDA Margin Statistics

 
You need to upgrade your Flash Player
EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector #
S&P 500 #
EBITDA Margin Statistics
High Average Low
0 % 0 % 0 %
 

EBITDA Margin Comment

Biotechnology & Drugs Industry experienced contraction in Ebitda by -20.51 % and Revenue by -3.44 %, while Ebitda Margin fell to 35.43 %, higher than Industry's average Ebitda Margin.

On the trailing twelve months basis Ebitda Margin in 1 Q 2017 fell to 38.51 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest ebitda margin. Total ranking remained unchanged compare to previous quarter at no. .

Other EBITDA Margins
Compare Industry's EBITDA margin to Pbi's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin

Biotechnology & Drugs Industry Operating Margin Statistics

 
Operating Margin Comment
Despite sequential Revenue deterioration in 1 Q 2017 of -3.44 % Biotechnology & Drugs Industry managed to reduce operating costs and increase Operating Profit by 16.26 %. Operating Margin grew to 30.57 % above Industry average Operating Margin.

On the trailing twelve months basis operating margin in 1 Q 2017 fell to 31.68 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest operating margin. Total ranking remained unchanged compare to previous quarter at no. .

Operating Margin Statistics
High Average Low
0 % 0 % 0 %
 
You need to upgrade your Flash Player
Operating Margin Industry Ranking
Within: No.
Healthcare Sector #
S&P 500 #

Biotechnology & Drugs Industry Pre-Tax Margin Statistics

 
You need to upgrade your Flash Player
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector #
S&P 500 #
Pre-Tax Margin Statistics
High Average Low
0 % 0 % 0 %
 

Pre-Tax Margin Comment

Biotechnology & Drugs Industry experienced contraction in Pre-Tax Income by -11.68 % and Revenue by -3.44 %, while Pre-Tax Margin fell to 19.47 %, higher than Industry's average Pre-Tax Margin.

On the trailing twelve months basis Pre-Tax Margin in 1 Q 2017 fell to 26.28 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest Pre-Tax Margin. Total ranking remained unchanged compare to previous quarter at no. .

Pre-Tax Margins
Compare Industry's pre-tax margin to Pbi's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Pbi's Competitors Industry Tax Rate

Biotechnology & Drugs Industry Net Margin Statistics

 
Net Margin Comment

Biotechnology & Drugs Industry experienced contraction in Net Profit by -30.82 % and Revenue by -3.44 %, while Net Margin fell to 14.08 %, higher than Industry's average Net Margin.

On the trailing twelve months basis Net margin in 1 Q 2017 fell to 35.1 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest Net margin. Total ranking remained unchanged compare to previous quarter at no. .

Net Margin Statistics
High Average Low
0 % 0 % 0 %
 
You need to upgrade your Flash Player
Net Margin Industry Ranking
Within: No.
Healthcare Sector #
S&P 500 #

Other Net Margins
Compare Industry's net margin to Pbi's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Pbi's Suppliers Definiton of Net Margin



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com